Back to catalog NATTY+

Tirzepatide

FDA-approved · dual incretin

Research use only. Sold for in vitro laboratory research use only. Not a drug, supplement or cosmetic. Not for human consumption or any in vivo use.

Dual GLP-1 / GIP receptor agonist. The molecule is approved in human medicine; the material supplied here is not an approved drug product and is for laboratory research only. Primary clinical literature: Jastreboff et al., New England Journal of Medicine, 2022 (n=2,539).

Molecular identity

Molecular weight4813.5 g/mol
Molecular formulaC225H348N48O68

Sizes & pricing

SizePriceAvailability
20mg$120
50mg$250
Get a restock alert
One email, when it lands. No list, no spam.
Purity>99%, HPLC & MS
TestingIndependent lab, every batch
FormLyophilized powder
ShippingFree over $100$10 under that

What you receive

Every batch is tested by an independent laboratory before it is listed — purity by HPLC, identity by mass spectrometry.

Handling & storage

0 in cart View cart →